• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS TINA-QUANT D-DIMER; FIBRIN SPLIT PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS TINA-QUANT D-DIMER; FIBRIN SPLIT PRODUCTS Back to Search Results
Catalog Number 04912551190
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/02/2015
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The customer received questionable d-dimer results for one patient sample.The patient was known to have results > 7500ug/l since 2010.The specific date of the event was requested, but was not provided.The initial result from integra 400 plus analyzer serial number (b)(4) was >7500 ug/l with a data flag.The repeat result was 18000 ug/l.The same sample was tested on a cobas6000 analyzer and the result was 7573 ug/l.The sample was then tested on a vidas analyzer and the result was 920 ug/l.The results were reported outside of the laboratory.The patient was not adversely affected and was did not receive any special treatment.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
The sample in question was sent to another laboratory and the results were provided as: "innovance siemens 950 and 920 tq roch c8000 4740 and 4770 stago sta lia-dd 1030 and 990 fdp test: 4,6 ug/ml (ref < 5 ug/ml) = normal comment second lab: "there seems to be no high degradation of fibine, which is equivalent to our hypothesis that something bothers in the dd test.".
 
Manufacturer Narrative
Sample from the patient was submitted for investigation and it was found a non-specific reaction from igm could have caused the high d-dimer result.The correct d-dimer result for the sample was thought to have been 1.08 ug feu/ml based on the converted values after absorption with anti-igm antibody.Product labeling documents in rare cases, specific immunoglobulins, particularly in samples from patients with myeloma, can give falsely high results.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TINA-QUANT D-DIMER
Type of Device
FIBRIN SPLIT PRODUCTS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5093545
MDR Text Key26483998
Report Number1823260-2015-04201
Device Sequence Number1
Product Code GHH
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
K062203
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Followup
Report Date 12/15/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number04912551190
Device Lot Number61323101
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Event Location Laboratory
Date Manufacturer Received09/02/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age065 YR
-
-